Since no single antigen is universally present in HCC, DCs pulsed with multiple tumor-associated antigens (TAA) including AFP, GPC-3, and MAGE-1 were reported to induce HCC-specific immune response [98,99]; although their clinical efficacy needs to be validated in a larger cohort of patients. The gene discussed is AFP; the disease is hepatocellular carcinoma.